Table 3.
Sources of Peptides and Their Sequences Presented by HLA-E During Interaction with CD94/NKG2
| Peptide source | Sequences | References |
|---|---|---|
| HLA-B7 | VMAPTRVLL | (10,46,79–81) |
| HLA-B27 | VTAPRTLLL | (46,80,81) |
| HLA-Cw7 | VMAPRTLLL | (50) |
| HLA-C*03:04 | VMAPRTLIL | (51) |
| HLA-G | VMAPRTLFL | (50) |
| CMV UL40 | VMAPRTLIL | (82) |
| VMAPRTLVL | ||
| Hepatitis C virus | YLLPRRGPRL | (83) |
| ABC MRP7 | ALALVRMLI | (84) |
| HIV p24 | AISPRTLNA | (85) |
Sequences: A, alanine; F, phenylalanine; G, glycine; I, isoleucine; L, leucine; M, methionine; N, asparagine; P, proline; S, serine; R, arginine; T, threonine; tyrosine; V, valine.
CMV, cytomegalovirus; NKG2, natural killer cell group 2.